Cardiopulmonary monitonng remains the mainstay of intensive-care unit utilization of clinical chemistry resources. Its focus has been on the restoration and maintenance of oxygen transport. Metabolic monitoring, a relatively new area of application for clinical chemistry technology, focuses on cell metabolism and on cell-cell interaction as a mechanism of metabolic regulation. This latter application of monitoring is developing as a result of a better understanding of the pathogenesis of organ dysfunction and disease processes in intensive-care unit patients. Some of the clinical chemistry technologies used include analyses for amino acids and polyunsaturated fatty acids, measurement of cytokine concentration and activity, nutritional assessment and monitoring, more sensitive monitors of liver function, and assessment of altered immunity in critically ill patients. Use of these technologies, along with specific support measures, offers new avenues for decreasing infectious complications and reducing mortality and morbidity of patients in intensive-care units.
We also present forthcoming metabolic monitors, with some discussion of their rationale and projected clinical utility.
AmIno Acids In Plasma
Spackman et al. (17) first introduced commercially automated data acquisition into amino acid analysis in 1958. In part for this work, they received a Nobel Prize in chemistry. Since that time, technical improvements in the instrumentation for amino acid analysis, along with an improved understanding of amino acid metabolism in ICU patients, have allowed its transition from a research tool to a useful analysis in clinical nutrition practice.
Amino acid analysis has had two general applications to physiological fluids. One, the detection and management of inborn errors of metabolism, will not be discussed in this paper. The other application, the subject of this section, is the evaluation of the metabolic response to injury and the development and monitoring of nutritional support regimens in the critically ill patient.
The earliest evaluation of amino acid technology was in patients with cirrhosis and encephalopathy. The low concentrations of branched-chain amino acids in plasma and the increases of aromatic and sulfur-containing amino acids were recognized as characteristicof the disease process, as was the increased concentration of glutamine in the spinal fluid. An amino acid formula was designed to normalize the proffleof amino acids in plasma when given in adequate doses. Clinical studies with this approach have demonstrated both improved recovery from encephalopathy and reduced mortality (18) (Figure 2 ).
When glucose-based nutrition was applied to patients in sepsis and hypermetabolism, several adverse consequences resulted: increased oxygen consumption and carbon dioxide production, increased catecholamine release, fatty liver, pulmonary failure, and poor support of protein synthesis ..iiIuces.
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Fig. 1. Statistically definedresponsestates
Thesolid inner circle represents the mean value from a nonstressedcontrolpopulation. Each dotted circlerepresentseither 3 or 4 SD from that mean. BOHB = -hydroxybutyrate; AcAc = acetoacetate;trig = triglyceride;BCAA = branched-chainamino acids; ABU = a-amino-n-butync acid;Gig = glucagon; Ins= insulin (19). Analysis of energy expenditure revealed that reduced caloric loads and reduced glucoseloads were necessary to avoid some of these complications in most patients. Amino acids were found to be the most effective anticatabolic support, primarily because they led to an increase in protein synthesis rate. Analysis of amino acid proffles and kinetics revealed an increased use of the branched-chain amino acids for energy, primarily in skeletal muscle, and an increased mobilization of amino acids from muscle stores and transport to active sites of protein synthesis and gluconeogenesis such as liver. Because of these findings and the ureagenic potential of standard amino acid formulas, new amino acid formulations were developed that were increased in the concentrations of branched-chain amino acids and decreased in the glucogenic and aromatic amino acids. Clinical studies with these new formulas have indicated that they are more efficient at promoting nitrogen balance while supporting hepatic protein synthesis and minimizing urea production (11). The low concentrations of glutamine in plasma from these metabolically stressed patients led to a series of investigations that focused on glutamine metabolism in septic states. The low concentration appears to be related to glutamine's role as a gut energy source and a trophic factor for the gut mucosa (20). Clinical studies are now underway to verifi the potential clinical utility of this amino acid.
In addition, argiine has been recognized as a modulator of lymphocyte proliferative response and as one of the products of the activated macrophage that can modulate hepatocellular function (21). Proposed effects of arginine will be discussed in greater detail later in this chapter.
Hepatic production of protein is closely related to the liver's clearance of amino acids. Experiences gained during liver transplantation led to this insight. In this setting the concentration of total free amino acidsin plasma increases fivefold over baseline during the anhepatic phase, then decreases to baseline values or below after successful allografting and production of acute-phase proteins (22,23). Consequently, this concept of examining amino acid clearance as a test of liver function was proposed (24). The conceptual framework of amino acid clearance has been concurrently developed by two groups of investigators. Clowes et al (25) developed the "central plasma clearance rate" of amino acids to measure the flux of amino acids The group that received amino acids (F080) had a faster and more complete recovery from the encephaiopathy of liver failure than did the nontreated controls and attained positive nitrogen balance between peripheral tissues (primarily skeletal muscle) and the visceral organs (liver). During exogenous infusion of amino acids, they measured blood flow while simultaneously quantifying arterial and femoral venous samples in amino acid analysis. The rate of amino acids extracted by the liver was calculated as the quantity of plasma (mL/m2 per minute) from which amino acids are cleared. This concept was then applied to patients who were septic or cirrhotic or who had undergone liver transplantation; the measurements were found to have prognostic significance (25, 26) . (27, 28) , while developing a canine model of global hepatic ischemia, developed a bolus technique for measuring clearance of amino acids from plasma. After taking a baseline blood sample, they delivered a bolus injection of amino acids (0.5 mL/kg of body wt.) via a venous line and took blood samples 2, 5, 10, and 20 mm post-injection. Using a fluorescent label (o-phthalaldehyde) that binds to an amino nitrogen, they could measure the total free amino acid content in plasma with a centrifugal analyzer and determine amino acid clearance (28). This clearance correlated closely with the hepatic energy state and had prognostic significance in liver transplantation as an index of allograft viability and function (22, 23, (29) (30) (31) (Figure 3) . Amino acid analysis is also used in assessing hepatic function and as a prognostic index in multiple organ failure syndrome (MOFS). This syndrome can develop after a variety of insults, including tissue injury or ischemia, severe hemorrhage, sepsis, and severe inflammation, as in pancreatitis (19, 32). It involves a complex interaction between the central nervous system, the endocrine system, and cell-cell communication mechanisms. Sequential organ involvement begins in the lung, then proceeds to the liver, kidney, and eventual collapse of the entire metabolic system. MOFS remains the cause of most mortality and prolonged ICU stays in surgical patients (33).
Konstantimdes et al
Current severity indexing systems are not applicable in Fig.3 . Plasmaamino acidclearance(PAAC) primarily occurs in the liver after a bolus of amino acids; the clearance rate closely correlates with the hepatic energy state, expressed as AlP production these clinical settings. Rather, metabolic variables must be considered because the process is one of metabolic failure that is poorly reflected in the initial physiology but becomes clinically manifest 7-10 days after injury. In settingswhere the serum bilirubin may not reflect this injury, such as hemolysis or hematoma resolution, the concentration of phenylalanine in plasma appears to reflect the hepatocellular function and to be of prognostic significance. This observation presumably reflects both the increased release of this amino acid from muscle and the reduced hepatic clearance as the liver function deteriorates during MOFS.
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Acute-Phase ProteIns and Nitrogen Balance
Visceral proteins, includingalbumin, prealbumin, tranaferrmn, and retinol-binding protein were first used in epidemiological surveys to evaluate nutritional states of populations. Later these proteins were used to evaluate the need for and response to specialized nutritional therapy (34-36). Although visceral proteins have been correlated with morbidity and mortality, they appear to have poor sensitivity and specificity as markers for nutritional status and as monitors of nutritional therapy in individual ICU patients with hypermetabolism and MOFS (37, 38).
Factors other than nutrient availability can influence the concentrations of visceral protein in serum. The most significant of these factors are hormones and mediators that regulate protein synthesis in hepatocytes. Tissue injury seems to stimulate the production of cytokines by macrophages, which in turn regulatehepatocytes to increase production of acute-phase reactants while decreasing the production of other proteins.
Although measurement of serum proteinsis easier than a nitrogen balance study, nitrogen balance remains the best bedside tool for assessment of protein utilization and overall nitrogen economy, even in the critically ill patient.
A negative nitrogen balance indicates net protein catabolism. A positive nitrogen balance indicates nitrogen retention and, when adjusted for changes in weight and blood urea nitrogen, generally correlates with net protein synthesis. During nutritional support, the goal is to achieve a nitrogen balance in the range of +2 to +4 g/day (39, 40). In a recent study of general surgical patients that was designed to evaluate the accuracy of estimating TUN output from the measured UUN, paired studies of UUN: TUN were performed on 421 24-h urine collections from general surgical/trauma patients. The variability of UUN as a percentage of TUN ranged from 12% to 100% (48). If these UUN values are used as estimates for TUN in calculating nitrogen balance, variations of up to 12 g/day could result (49) . This study also demonstrated that the correction factor of 1.25 for estimating TUN from UUN was not reliable.
Achieving this endpoint indicates that the
Elsewhere we suggested (50) that Pyro-Chemiluminescence'', which has excellent correlation with the classic Kjeldahl technique, can be used for determining nitrogen content in urine, feces, and other biological fluids cheaply, rapidly, and in real-time (51) (52) (53) (54) . In the absence of clinically useful markers of protein synthesis in these ICU settings, nitrogenbalance will probably remain the dominant marker of nutritional outcome.
Ketone BodIes
Ketone bodies (acetoacetate and /3-hydroxybutyrate) are produced exclusively in the liver by partial oxidation of fatty acids. These ketones can be oxidized for energy metabolism, and are primarily utilized by cardiac and skeletal muscle during glucose deprivation. (16, 61) . Functional failure of the liver is increasingly being recognized as a key factor in the pathogenesis of postoperative MOFS (5, 62) .
The reduction of acetoacetate to /3-hydroxybutyrate is a key metabolic reaction within liver mitochondria and involves the production of energy-rich ketone bodies. The amount of conversion of acetoacetate to /3-hydroxybutyrate is determined by the ratio of NADH to NAD. Indeed, the relative amounts of the two oxybutyrates produced by the liver are used as an index of the state of reduction of NA]) ± in mitochondria. The formation of hydroxybutyrate is done by withdrawing electrons from the mitochondria to make a more reduced substrate. Later oxidation of the compound in peripheral tissue can produce more high-energy phosphates than does oxidation of acetoacetate (63) . Inhibition of the electron-transport system may be caused by mitochondrialimpairment, hypoxia, and hypotension (64, 65) . Because both acetoacetate and /3-hydroxybutyrate freely cross the cell membrane, abnormalities of this ratio can easily be detected by arterial blood measurements.
Patients with severe hepatic failure tend to die when the arterial blood ketone body ratio decreases markedly, concomitant with a marked decrease in the hepatic energy charge (66-68). Although the regulating mechanism remains to be clarified, ketogenic adaptation in the liver may play an important role in restoring mitochondrial impairment (69) . As the arterial ketone body ratio decreases, hepatic fatty acid oxidation is enhanced with a tendency toward increased ketogenesis. However, while ketogenic adaptation progresses dramatically, as evidenced by a further decrease in the arterial ketone body ratio, prolongation of that state reduces the ketone body ratio, because even fatty acids can no longer be utilized in the terminal state.
The relation of arterial ketone body ratio to clinical status has been examined in a prospective study of 55 patients undergoing major abdominal surgery (70) . Ozawa et al. (70) found that patients whose ketone body ratio never fell below 0.7 had an uncomplicated postoperative recovery. Of patients in whom the ratio fell to <0.25, nearly all went into pulmonary, hepatic, renal, cerebral, and cardiac failure. In patients with transient organ failure before recovery, the ketone body ratio fell and rose accordingly.
Plasma amino acids were also measured in several of these patients; the blood ketone body ratio correlated negatively with alanine, proline, phenylalanine, and tyrosine. Ozawa et al. suggest that when the ketone body ratio was reduced, entry of these amino acids into the Krebs cycle was inhibited, leading to an accumulation in the blood. Hepatic metabolism played a key role in this study, with 85% of their patients having hepatobiliary disorders; the remaining 15% belonged to the mildest category of ketone body ratio abnormality.
Recently, a study of surgical stress in a random selection of 60 patients undergoing elective laparotomy was performed, utilizing arterial ketone body ratio and a hepatic stress score (total area below the ketone body ratio of 0.7) (71) . This measure of hepatic functional capacity indicated a causative relationship between suppression of hepatic energy metabolism during the operation and enhanced postoperative catabolic response. Results suggest that total surgical stress in major laparotomy can be quantified and evaluated through the magnitude of decrease in hepatic mitochondrial redox potential.
Each organ is functionally integrated with all others by an extensive metabolic regulation system. The exchange of energy and substrates between organs is crucial for inducing the steady-state favorable to maintaining life. The liver plays a central role in this homeostasis and is being increasingly recognized as a critical organ in the pathogenesis of MOFS. Evidence now suggests that the functional reserve of the liver can be noninvasively estimated by determining the ketone body ratio, which may function as a systemic indicator of metabolic derangement.
Cytoklnes
Recent advances in molecular biology have allowed the recognition of a multitude of factors involved in the regulation of cell growth and metabolic functions. New developments in molecular techniques have made possible the purification, characterization, and eventual production by recombinant technology of many of these substances. Cytokines, soluble factors that can modi1y the response and (or) growth pattern of other cells (72) , are produced by a variety of cells, including blood monocytes, tissue macrophages, keratinocytes, and endothelial cells (73) . Cytokines resemble hormones in their mechanisms of action, but are released and active at such a small amount that they usually are not detectable in the systemic circulation (72) . These mediators, such as tumor necrosis factor (TNF; also known as "cachectin") and the interleukins (ILs), play a determining role in the regulation of cellular processes, which include immune recognition, differentiation, and cell proliferation (74) (75) (76) . Early studies on the metabolic effects of cytokines demonstrated that bacterial endotoxins were potent stiinulators of IL-i and TNF (77) (78) (79) . Later studies, using recombinant versions of IL-i-a and -/3and TNF-a and -/3, revealed that these cytokines could stimulate each other's production (80, 81) and act synergistically (82, 83). TNF, now termed TNF-a, was originally identified as a product of macrophage stimulation by endotoxin (84) . The primary effect of TNF on tumor tissue is hemorrhagic necrosis; it also increases the permeability of vessel walls. In vitro analysis has revealed potent inhibitory effects on erythroid/myeloid proliferation, activation of neutrophils, and intrinsic antiviral activity (72) . TNF has been correlated with increased muscle energy production by promoting "futile cycles," i.e., energy that cannot be converted into muscle contraction, and results in loss of lean body mass (85) .
IL-i, which starts T-cell proliferation and activates T-cell production of gamma interferon and IL-2, has been identified as a potent mediator of inflammation, causing fever, release of acute-phase proteins, cartilage breakdown, and activation of neutrophils, macrophages,and T lymphocytes (86) . IL-2 is secreted by activated T helper cells in response to antigen presentation. IL-2 is taken up by activated T killer cells, which thereby become fully activated, capable of destroying target cells such as cancer or viral infected cells (87) .
Although TNF-a and ILs affect many cell functions, their molecular mechanisms of action are not understood. Most cytokines must bind to a specific receptor on their target cell to produce an intracellular signal ("second message"), resulting in a cellular response (72, 88) . A number of second messengers such as cAMP and protein kinase C have been described (89) . It has been hypothesized that each cytokine has a cascade system that consists of several messengers and resultsin delivery of its own individual signal to the cell. In addition, this system may modulate receptor expression to other substances, thereby altering cellular response to these factors (72) . The end result of this process is the modulation of gene expression, which may occur at the transcription of mRNA from DNA or at the translation of mRNA into protein. The signal may be stimulatory or inhibitory (72, 90) .
Normal physiological production of cytokines results in stimulation and enhancement of immune system activity. However, greater cytokine production, particularly of TNFa, is toxic to the host (91) . Recent studies demonstrate that an exaggerated TNF response often leads to hemodynainic collapse, shock, and death (92) . TNF-a has been implicated as a mediator that is releasedin response to lipopolysaccharide (endotoxin) stimulation and is capable of initiating multiple organ injury (93,94).
It has been suggested that the deleterious effect associated with TNF in human septic shock occurs in cooperation with other factors. Prostaglandins and leukoti-ienes have been implicated in the shock-like hypothermic effects of TNF-a when given at doses in the pathological range (95). A recent study demonstrated that during the initial phase of meningiococcal septic shock IL-6 and IL-i are released into serum, and concurrently are found with TNF-a and lipopolysaccharide in the systemic circulation. High concentrations of IL-6 in serum were associated with fatal outcome. IL-i was exclusively detected in patients who had high concentrations in serum of IL-6, TNF-a, and lipopolysaccharide, and had a rapid fatal outcome (96) .
Complex interactions between nutrition, infections, and diseases that have an inflammatory component are currently an area of intense investigation. Cytokines are well recognized to play an essential role in these interactions.
Numerous studies show that nutritional factors affect the tissue targets of cytokine action and the cells of the immune system from which cytokines are produced. Therefore, nutrients and nutritional status not only may influence the ability of diseased and traumatized individuals to producecytokines, but also may affect subsequent cytokine actions (97) . In vitro studieswith IL-i, TNF-a, and IL-6 suggest that cytokines are central to the stimulation of acute-phase protein synthesis and alterations in the serum protein profile during an inflammatory response (98, 99) .
Evidence of malnutrition is the common feature in decreased cytokine production in studies of hospitalized patients. Improvement in the ability to produce cytokines has been noted in some patients, which was related to protein intake; patients who showed no improvement had a high mortality rate (100) . We cannot determine from the data in these studies whether IL-i, IL-6, or TNF-a production was reduced specifically, because the bioassaysused did not differentiate between these cytokines (97).
Deficiencies of trace elements and vitamins are com-
monly found in malnourished populations. However, few studies have investigated the effects of individual deficiencies on cytokine production or actions (97) . Peritoneal macrophages from severely iron-deficient rats were noted to have impaired ability to produce cytokines, whereas treating anemic rheumatoid patients with iron exacerbated inflammatory symptoms (101, 102) . Reduction in cytokine production was noted in a recent study in which mice receiving a copper-deficient diet showed only 64% of the normal increase in spleen cells when exposed toE. coli lipopolysaccharide
(103).
Of the vitamins, vitamin A is particularly important in maintaining adequate cell-mediated immunity. A study by Moriguchi and Werner (104) showed that stimulated peritoneal macrophages of mice given i6 times the normal intake of vitamin A showed a twofold increase in IL-i production. It is unclear whether the reduced resistance to infection found during vitamin A deficiency, or the antitumor effect of high doses of retinoids, is significant.
Future Directions
Further investigation examining the precise way in which specific nutrients exert effects on production and action of cytokines is necessary. Insufficiency of nutrients may prevent cytokines from optimizing beneficial effects in the recovery process. A more complete understanding of nutrient-cytokine and cytokine-cytokine interactions is also important in situations where cytokines are being used therapeutically, such as in cancer treatment. However, interpretation of study results must be approached with caution. The significance of cytokine concentrations in plasma is questionable, given growing evidence that cytokines are rapidly cleared from the circulation (97) . The likelthood that many cytokines are produced locally and act locally makes development of reliable methodology to observe these phenomena a priority. In addition, the synergistic interaction of cytokines, particularly in inflammatory diseases, suggests that caution should be exercised in interpreting the activity of a single cytokine. The use of monoclonal antibodies for cytokines will help clarify mechanisms of action and enable more discerning evaluation of data from these studies.
Their potential utility
in predicting the development of shock states and in monitoring and predicting outcome also remains to be evaluated.
Immune FunctIon
Suboptimal nutrition results in profound compromiseof the immune response (105, 106) . Negative nitrogen balance, weight loss, and substantial immune dysfunction are common sequelae of major surgery, various disease states, and trauma. While positive nitrogen balance and weight gain can be accomplished through perioperative enteral and parenteral nutrition, the general effects of nutritional support on immune function are unclear (107, 108) . Nutritional support can reduce the morbidity and mortality associated with starvation. However, it has not altered the course of disease, including hypermetabolism and MOFS in the critically ill patient (109) . Substrates in the nutrition regimen apparently affect nutritional and nonnutritional markers. Recent data suggest that nutrients such as arginine (21) , polyunsaturated fatty acids (110) , and purines/pyrimidines (111) may profoundly affect lymphocyte function, even under conditions of infection or major general surgery (112) .
Arginine
Arginine is a nitrogen-dense amino acid having multiple biologically important properties. A semi-essential amino acid, it is required for growth and for recovery in posttraumatic states (113, 114) . Arginine is a potent secretogog, influencing many endocrine glands, and appears to be a modulator of the immune system (114) (115) (116) . In humans, arginine supplementation increases blastogenesis of peripheral blood lymphocytes in response to certain mitogens (117) . Arginine prevents or diminishes the reduction in blastogenesis in immunosuppressed and postoperative cancer patients (118) . Improved mitogenesis has been observed in patients who are positive for Human Immunodeficiency Virus, although without apparent effect on peripheral lymphocyte ratios (119) .
Ribonucleic Acid
Investigations over the past several years have revealed the vital role dietary nucleotides play in the maintenance ofT-lymphocyte-mediated immunity. Nucleotides are precursors of DNA and RNA, which are necessary for protein synthesis and cell mitosis. They play major roles in almost all biochemical processes. The liver has been suggested to be a major source of preformed purines and pyrimidinesfor other tissues, but comparative contributions are not well documented. Bases or nucleosides are re-utilized through salvage pathways and are degraded when not required. Both dietary pyrimidines and purines decrease de novo pyrimidine biosynthesis in humans (120) , and dietary uracil contributes to cellular pyrimidine pools (121) .
Removal of dietary nucleotides results in suppression of cellular immune responses (122, 123) , which, in part, is a result of a block in lymphocyte maturation (124) . Provision of uracil, unlike adenine, has demonstrated restoration of delayed-type hypersensitivity response to various foreign antigens in mice (125, 126) . Dietary nucleotides may also be effective in macrophage activation of the T helper! inducer population (127) . In experimental settings, uracil has been demonstrated to reverse the immunosuppression associated with blood transfusion.
Omega-3 Fatty Acids
Lipid intake can exert metabolic effects by altering the fatty acid composition of cell membranes (128) . The lipid composition of membranes alters membrane fluidity and the generation of second messengers, and thus the pattern of prostaglandin and leukotrienesynthesisischanged by alterations in lipid substrate (129) . Generally, the eicosapentanoic acid (20:5 n-3) products are less inflammatory than those of linoleic acid (18:2 n-6)(130). A relative excess of linoleic acid substrate stimulates production of prostaglandin PGE2, which decreases the ability of cytokines to stimulate IL-2 synthesis by endothelial cells (131).
The release of dienoic eicosanoids and TNF, and IL-i released by Kupffer cells, are directly related to the amount of n-6 PUFA in the cell membrane. The incorporation of the PUFAs into cell membranes can occur within hours of ingestion and become stabilized within two to four days. In animal models, incorporation of n-3 PUFA into cell membranes of the hepatic macrophages, with a reduction in the n-6 content, was associated with a reduction in mortality in the presence of cecal ligation and puncture peritonitis.
In models of allogenic stimulation, such as the popliteal lymph node assay system, n-3 PUFA was associated with a return in the proliferative response in a magnitude equivalent to RNA.
The interrelationship between altered immune function and nutritional status has been difficult to define.Many factors other than nutritional status may result in an altered immune response of the hospitalized patient. In addition, existing tests of immune function tend to lack both sensitivity and specificity, further confounding delineation of the relationship between nutritional status and immune function. Recently,new methodology has also been described to quantify the release of important cell-surface markers into a plasma or culture supernate. Cellsactively participating in an immune response will shed physiologically important markers such as IL-2 receptors and CD8 molecules. The concentrations of these markers found in the circulation have been shown to be important predictors of immune response capability in several models. The assays are enzyme-linked immunosorbent assay procedures and are easily performed (133).
Study Methods
In
Tests for neutrophil and monocyte function are also readily available. Recent studies indicate that nutrients such as argiine, RNA, and n-3 PUFA, all targeted to improve T-lymphocyte function and to alter macrophage activity, can significantly improve the in vitro tests of lymphocyte function that evaluate proliferative responses to stimulation by specific and nonspecific antigens. The utility of these nutrients in altering clinical outcome for patients is also currently in clinical testing (113) .
